Literature DB >> 9609514

Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes.

J E Parker1, G J Mufti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9609514     DOI： 10.1046/j.1365-2141.1998.00708.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

Review 1.  Myelodysplasia and apoptosis: new insights into ineffective erythropoiesis.

Authors:  A A van de Loosdrecht; E Vellenga
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

Review 2.  The erythroblastic island.

Authors:  Deepa Manwani; James J Bieker
Journal:  Curr Top Dev Biol       Date:  2008       Impact factor: 4.897

3.  Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients.

Authors:  S Jilg; V Reidel; C Müller-Thomas; J König; J Schauwecker; U Höckendorf; C Huberle; O Gorka; B Schmidt; R Burgkart; J Ruland; H-J Kolb; C Peschel; R A J Oostendorp; K S Götze; P J Jost
Journal:  Leukemia       Date:  2015-07-08       Impact factor: 11.528

4.  cDNA cloning, expression pattern, and chromosomal localization of Mlf1, murine homologue of a gene involved in myelodysplasia and acute myeloid leukemia.

Authors:  J K Hitzler; D P Witte; N A Jenkins; N G Copeland; D J Gilbert; C W Naeve; A T Look; S W Morris
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 5.  Important features of myelodysplastic syndrome.

Authors:  Wolf K Hofmann; H Phillip Koeffler
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 6.  Current therapy of myelodysplastic syndromes.

Authors:  Amer M Zeidan; Yuliya Linhares; Steven D Gore
Journal:  Blood Rev       Date:  2013-07-27       Impact factor: 8.250

7.  Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.

Authors:  Elaine M Sloand; Lori Mainwaring; Monika Fuhrer; Shakti Ramkissoon; Antonio M Risitano; Keyvan Keyvanafar; Jun Lu; Atanu Basu; A John Barrett; Neal S Young
Journal:  Blood       Date:  2005-04-12       Impact factor: 22.113

Review 8.  Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Authors:  Stephanie Beurlet; Christine Chomienne; Rose Ann Padua
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

9.  Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.

Authors:  Sudeshna Seal; David M Hockenbery; Emily Y Spaulding; Hans-Peter Kiem; Nissa Abbassi; H Joachim Deeg
Journal:  Exp Hematol       Date:  2008-10-05       Impact factor: 3.084

Review 10.  Myelodysplastic syndromes: what do hospitalists need to know?

Authors:  Amer M Zeidan; Bishoy Faltas; B Douglas Smith; Steven Gore
Journal:  J Hosp Med       Date:  2013-05-11       Impact factor: 2.960
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.